소아 알레르기 질환의 발생과 면역치료

참고문헌 (66)

1. Strachan DP, "Hay fever, hygiene, and household size", BMJ, 299(6710), pp.1259~1260 (1989)
2. Lynch SV, "Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children", J Allergy Clin Immunol, 134(3), pp.593~601 e12 (2014)
3. Thorne PS, "Endotoxin exposure is a risk factor for asthma : the national survey of endotoxin in United States housing", Am J Respir Crit Care Med, 172(11), pp.1371~1377 (2005)
4. Braun-Fahrländer C, "Environmental exposure to endotoxin and its relation to asthma in school-age children", N Engl J Med, 347(12), pp.869~877 (2002)
5. Strachan DP, "Siblings, asthma, rhinoconjunctivitis and eczema : a worldwide perspective from the International Study of Asthma and Allergies in Childhood", Clin Exp Allergy, 45(1), pp.126~136 (2015)
6. Celedon JC, "Day care attendance in early life, maternal history of asthma, and asthma at the age of 6 years", Am J Respir Crit Care Med, 167(9), pp.1239~1243 (2003)
7. Ownby DR, "Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age", JAMA, 288(8), pp.963~972 (2002)
8. Hesselmar B, "Allergy in children in hand versus machine dishwashing", Pediatrics, 135(3), pp.e590~e597 (2015)
9. Metsälä J, "Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood", Clin Exp Allergy, 45(1), pp.137~145 (2015)
10. Tollånes MC, "Cesarean section and risk of severe childhood asthma : a population-based cohort study", J Pediatr, 153(1), pp.112~116 (2008)
11. Weber J, "Asthma and the hygiene hypothesis. Does cleanliness matter?", Am J Respir Crit Care Med, 191(5), pp.522~529 (2015)
12. Kim H, "Birth mode, breastfeeding, pet exposure, and antibiotic use : associations with the gut microbiome and sensitization in children", Curr Allergy Asthma Rep, 19(4), pp.22~ (2019)
13. Penders J, "Factors influencing the composition of the intestinal microbiota in early infancy", Pediatrics, 118(2), pp.511~521 (2006)
14. Ege MJ, "Exposure to environmental microorganisms and childhood asthma", N Engl J Med, 364(8), pp.701~709 (2011)
15. Kong HH, "Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis", Genome Res, 22(5), pp.850~859 (2012)
16. Abrahamsson TR, "Low diversity of the gut microbiota in infants with atopic eczema", J Allergy Clin Immunol, 129(2), pp.434~440 (2012)
17. Bisgaard H, "Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study", BMJ, 341, pp.c4978~ (2010)
18. Bisgaard H, "Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age", J Allergy Clin Immunol, 128(3), pp.646~652 e1-e5 (2011)
19. Fujimura KE, "Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation", Nat Med, 22(10), pp.1187~1191 (2016)
20. Wing K, "CTLA-4 control over Foxp3+ regulatory T cell function", Science, 322(5899), pp.271~275 (2008)
21. Jutel M, "IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy", Eur J Immunol, 33(5), pp.1205~1214 (2003)
22. Gri G, "CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction", Immunity, 29(5), pp.771~781 (2008)
23. Ring S, "CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue", Eur J Immunol, 36(11), pp.2981~2992 (2006)
24. Meiler F, "Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors", Allergy, 63(11), pp.1455~1463 (2008)
25. Jaffar Z, "Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways", Eur J Immunol, 39(12), pp.3307~3314 (2009)
26. Akdis M, "Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells", J Exp Med, 199(11), pp.1567~1575 (2004)
27. Russell SL, "Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma", EMBO Rep, 13(5), pp.440~447 (2012)
28. Herbst T, "Dysregulation of allergic airway inflammation in the absence of microbial colonization", Am J Respir Crit Care Med, 184(2), pp.198~205 (2011)
29. Mazmanian SK, "An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system", Cell, 122(1), pp.107~118 (2005)
30. Atarashi K, "Induction of colonic regulatory T cells by indigenous Clostridium species", Science, 331(6015), pp.337~341 (2011)
31. Gollwitzer ES, "Lung microbiota promotes tolerance to allergens in neonates via PD-L1", Nat Med, 20(6), pp.642~647 (2014)
32. Scharschmidt TC, "A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes", Immunity, 43(5), pp.1011~1021 (2015)
33. Smits HH, "Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin", J Allergy Clin Immunol, 115(6), pp.1260~1267 (2005)
34. Potter PC, "Update on sublingual immunotherapy", Ann Allergy Asthma Immunol, 96(2 Suppl 1), pp.S22~S25 (2006)
35. Dretzke J, "Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis : a systematic review and indirect comparison", J Allergy Clin Immunol, 131(5), pp.1361~1366 (2013)
36. Möller C, "Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis(the PAT-study)", J Allergy Clin Immunol, 109(2), pp.251~256 (2002)
37. Kuna P, "Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children", J Allergy Clin Immunol, 127(2), pp.502~508 e1-6 (2011)
38. Keskin O, "The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis", Pediatr Allergy Immunol, 17(6), pp.396~407 (2006)
39. Schmitt J, "Allergy immunotherapy for allergic rhinitis effectively prevents asthma : Results from a large retrospective cohort study", J Allergy Clin Immunol, 136(6), pp.1511~1516 (2015)
40. Ippoliti F, "Immunomodulation during sublingual therapy in allergic children", Pediatr Allergy Immunol, 14(3), pp.216~221 (2003)
41. Bufe A, "Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms : a doubleblind placebo-controlled study", Allergy, 59(5), pp.498~504 (2004)
42. Rolinck-Werninghaus C, "A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy(SLIT)in children with seasonal allergic rhinoconjunctivitis to grass pollen", Allergy, 59(12), pp.1285~1293 (2004)
43. De Bot CM, "Sublingual immunotherapy not effective in house dust miteallergic children in primary care", Pediatr Allergy Immunol, 23(2), pp.151~159 (2012)
44. Okubo K, "Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis", J Allergy Clin Immunol, 139(6), pp.1840~1848 (2016)[DOI]
45. Novembre E, "Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis", J Allergy Clin Immunol, 114(4), pp.851~857 (2004)
46. Marogna M, "Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study", Ann Allergy Asthma Immunol, 101(2), pp.206~211 (2008)
47. Eifan AO, "Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic", rhinitis children sensitized to house dust mite : an open randomized controlled trial, 2010, pp.40(6), 922~932
48. Yukselen A, "Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma : a randomized, placebo-controlled, double-blind, doubledummy study", Int Arch Allergy Immunol, 157(3), pp.288~298 (2012)
49. Jones SM, "Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults", J Allergy Clin Immunol, 139(4), pp.1242~1252 e9 (2017)
50. Shreffler WG, "Efficacy and safety of long-term epicutaneous immunotherapy (EPIT) treatment of peanut allergy with Viaskin® peanut: results of the twoyear extension of the VIPES phase IIb clinical trial", J Allergy Clin Immunol, 139(2), pp.AB377~ (2017)
51. Patterson AM, "Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis", Ann Allergy Asthma Immunol, 116(2), pp.168~170 (2016)
52. Hylander T, "Intralymphatic allergen-specific immunotherapy : an effective and safe alternative treatment route for pollen-induced allergic rhinitis", J Allergy Clin Immunol, 131(2), pp.412~420 (2013)
53. Cork MJ, "Epidermal barrier dysfunction in atopic dermatitis", J Invest Dermatol, 129(8), pp.1892~1908 (2009)
54. Irvine AD, "Filaggrin mutations associated with skin and allergic diseases", N Engl J Med, 365(14), pp.1315~1327 (2011)
55. Czarnowicki T, "Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march", J Allergy Clin Immunol, 139(6), pp.1723~1734 (2017)
56. Salimi M, "A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis", J Exp Med, 210(13), pp.2939~2950 (2013)
57. Murakami-Satsutani N, "IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand", Allergol Int, 63(3), pp.443~455 (2014)
58. Demehri S, "Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma", PLoS Biol, 7(5), pp.e1000067~ (2014)
59. Dubrac S, "Atopic dermatitis : the role of Langerhans cells in disease pathogenesis", Immunol Cell Biol, 88(4), pp.400~409 (2010)
60. Pabst RC, "The effect of application of aquaphor on skin condition, fluid requirements, and bacterial colonization in very low birth weight infants", J Perinatol, 19(4), pp.278~283 (1999)
61. Simpson EL, "Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention", J Allergy Clin Immunol, 134(4), pp.818~823 (2014)
62. Warner JO, "A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis : 18 months’ treatment and 18 months’ posttreatment follow-up", J Allergy Clin Immunol, 108(6), pp.929~937 (2001)
63. Schneider L, "Study of the atopic march : development of atopic comorbidities", Pediatr Dermatol, 33(4), pp.388~398 (2016)
64. Lai T, "Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma : a systematic review and meta-analysis", Sci Rep, 5, pp.8191~ (2015)
65. Wenzel S, "Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist : a randomised double-blind placebocontrolled pivotal phase 2b dose-ranging trial", Lancet, 388(10039), pp.31~44 (2016)
66. Gauvreau GM, "Effects of an anti-TSLP antibody on allergen-induced asthmatic responses", N Engl J Med, 370(22), pp.2102~2110 (2014)

관련 논문AI추천